Silverarc Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,000
Closed -$2.86M 83
2023
Q2
$2.86M Hold
200,000
0.89% 35
2023
Q1
$1.43M Buy
+200,000
New +$1.43M 0.59% 46